CD274 and neoplasm: Moreover, the association between patients’ responses to anti-PD-L1 treatment with atezolizumab and the expression of PD-L1 on tumor-infiltrating immune cells reached statistical significance in several tumors, whereas the association between the treatment responses and PD-L1 expression on tumor cells did not.